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The Relationship between Media and Public Opinion 
Regarding Cannabis as an Opioid Substitute 
According to the 2018 Centers for Disease Control and Prevention (CDC) Drug 
Surveillance Report, a total of 191,146,822 opioid prescriptions were filled by retail pharmacies 
in the United States during 2017 (p. 10). Opioids are a broad class of pain-relieving drugs 
encompassing many different medications used for numerous conditions. As reported by the 
National Academies of Sciences, Engineering, and Medicine (NASEM, 2017a), there are many 
different types of prescription opioids (e.g., hydrocodone, morphine, fentanyl, etc.) that “differ in 
their chemical composition, route of administration, uptake, distribution, type/rate of elimination, 
and ability to bind to opioid receptors” (p. 53). Despite these differences, their effects are 
generally the same; they inhibit the perception of pain by binding to μ opioid receptors on 
nervous system cells (NASEM, 2017a). 
While opioids have proven to be effective pain-relievers for forms of acute and subacute 
pain, there is little evidence behind the efficacy of their use for chronic pain (Sehgal, Colson, & 
Smith, 2013; Chou et al., 2015). According to Sehgal et al. (2013), “RCTs [randomized 
controlled trials] that evaluate long-term (16 weeks or longer) efficacy of opioids are lacking. No 
study has shown clinically significant (≥50% pain reduction) and sustained pain relief with 
opioids over several months and years” (Sehgal et al., 2013, p. 1202). Furthermore, not only is 
there little evidence to support the use of opioids for chronic pain, but there is also growing 
concern over the potential abuse and risk of overdose associated with their long-term use. 
The Opioid Crisis 
According to the previously mentioned CDC Drug Surveillance report (2018), an 
estimated 11,517,000 people reported they misused their prescription pain reliever in 2016 (p. 
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14). Furthermore, the report also adds that 42,249 people died from an opioid overdose in 2016, 
with 17,087 coming from prescription opioids (CDC, 2018, p. 23-24). These statistics highlight 
two significant problems in the United States: 1) there is an issue with the prescription rate of 
opioids and 2) too many people wind up overdosing from their prescription. It has become such a 
rampant issue that President Trump declared it a public health emergency in 2017. During his 
declaration, he stated, “No part of our society — not young or old, rich or poor, urban or rural — 
has been spared [by] this plague of drug addiction and this horrible, horrible situation that’s 
taken place with opioids” (as cited in Davis, 2017). Evidently, there is a need for opioid 
substitutes that are effective in their treatment yet limited in their side effects and the 
consequences of their abuse. 
Cannabis 
One potential substitute that has gained popularity in recent years is cannabis. Commonly 
referred to as medical marijuana, the term cannabis is used to describe any drug that is derived 
from the plant genus cannabis (Whiting et al., 2015). It is composed of over 80 different 
components, termed cannabinoids, which are capable of producing a variety of effects. 
Cannabinoids produce these effects by binding to cannabinoid receptors located throughout the 
body (Wallace, Marcotte, Umlauf, Gouaux, & Atkinson, 2015; Schrot & Hubbard, 2016). These 
receptors are normally activated by endogenous cannabinoids (endocannabinoids), which help 
regulate numerous bodily functions—including pain perception. Evidence suggests that 
cannabinoids produce most of their pain-relieving effects through the CB1 subtype of 
cannabinoid receptors, but CB2 receptors may also play a role (Pertwee, 2009). 
Over the past several decades, cannabis has been legalized for medicinal purposes in 31 
states, the District of Columbia (DC), Guam, and Puerto Rico (Hanson & Garcia, 2018). 
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However, only three cannabinoid drugs have been approved by the United States Food and Drug 
Administration (FDA)—Dronabinol, Nabilone, and Epidiolex (Schrot & Hubbard, 2016; FDA, 
2016). According to Schrot and Hubbard (2016), Dronabinol is used to treat anorexia in human 
immunodeficiency virus (HIV) patients with severe weight loss and, along with Nabilone, to 
curb nausea in chemotherapy patients. Additionally, Epidiolex is used to treat two severe forms 
of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome (FDA, 2018). 
Despite there only being three FDA approved cannabinoid drugs, there is reason to 
suspect more could be approved in the future. During the press announcement for the approval of 
Epidiolex, the FDA commissioner, Scott Gottlieb, stated, “This approval serves as a reminder 
that advancing sound development programs that properly evaluate active ingredients contained 
in marijuana can lead to important medical therapies” (FDA, 2018). This means that more 
cannabinoid drugs may become available in the future if adequate research is conducted into the 
different components of cannabis. Even so, while there is potential for more cannabinoid drugs 
to be approved by the FDA and many states are legalizing the use of cannabis for medicinal 
purposes, it is necessary to determine if cannabis can be an effective analgesic medication. If not, 
there is little reason for its use as an opioid substitute. 
Efficacy and Safety of Cannabis 
Recent studies have found that cannabis is an effective analgesic drug for acute pain. For 
instance, De Vita, Moskal, Maisto, and Ansell (2018) conducted a systematic review and meta-
analysis of 18 studies and found that cannabinoid use led to a significant, yet small, increase in 
pain threshold; a significant small-to-medium decreased unpleasantness rating; a significant 
small-to-medium increase in pain tolerance; and no significant association with ongoing 
experimental pain intensity or mechanical hyperalgesia (De Vita et al., 2018). The researchers 
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also found that higher doses of cannabinoids had a greater significant analgesic effect than lower 
doses (De Vita et al., 2018).  
In another study, Wallace et al. (2015) conducted a randomized, placebo-controlled, 
crossover study of 16 subjects with diabetic peripheral neuropathic pain. After having each 
participant undergo 4 single dosing sessions, the researchers found that there was a significant 
reduction in pain correlated with an increase in tetrahydrocannabinol (THC) concentration from 
the placebo to the low (1% THC), low to medium (4% THC), and medium to high (7% THC) 
concentration groups (Wallace et al., 2015). 
Furthermore, Wilsey et al. (2016) conducted a randomized, placebo-controlled, crossover 
study of 42 subjects with central neuropathic pain and found cannabis was effective in reducing 
pain, but, unlike the studies by De Vita et al. and Wallace et al., pain relief was not significantly 
associated with the concentration of THC (Wilsey et al., 2016). Therefore, while all three of the 
aforementioned studies support the use of cannabis for acute pain (Wallace et al., 2015; De Vita 
et al., 2018; Wilsey et al., 2016), more research is needed to determine the relationship between 
cannabinoid concentration and analgesic effect. 
Cannabis has also been shown to be effective in treating chronic pain. In a 2015 
systematic review and meta-analysis, Whiting et al. assessed 28 studies (63 reports; 2454 
participants) to determine the analgesic effectiveness of different forms of cannabinoids 
including nabiximols, smoked THC, nabilone, THC oromucosal spray, dronabinol, vaporized 
cannabis, ajuvenic acid capsules, and oral THC. The researchers found moderate-quality 
evidence to support the use of cannabinoids to treat chronic pain (Whiting et al., 2015). They 
also found there was an increased risk of short-term adverse events, which included “asthenia, 
balance problems, confusion, dizziness, disorientation, diarrhea, euphoria, drowsiness, dry 
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mouth, fatigue, hallucination, nausea, somnolence, and vomiting” (Whiting et al., 2015, p. 2467). 
However, they were unable to identify a study that assessed the long-term adverse events 
associated with cannabis use (Whiting et al., 2015). 
Yet, in a following study, Ware, Wang, Shapiro, and Collet (2015) assessed the long-term 
efficacy and safety risks associated with the use of cannabis over a 1-year period, which they 
state is the first cohort study of its kind. They found that cannabis use over the 1-year period was 
associated with a reduction in the sensory component of pain, an improvement in the total 
symptom distress score of the Edmonton Symptom Assessment Scale, and a significant 
improvement in the total mood disturbance scale of the Profile of Mood States (Ware et al., 
2015). They also found no significant increase in serious adverse events between the control and 
medical cannabis groups but did find an increase in the number of non-serious adverse events, 
which included headache, nasopharyngitis, nausea, somnolence, and dizziness (Ware et al., 
2015).  
Even so, one important adverse event that is absent in the studies by Whiting et al. and 
Ware et al. is death due to cannabis overdose. Along with these two studies, a recent NASEM 
(2017b) report found no sufficient evidence to support or refute the claim that there is a 
significant link between cannabis use and death due to overdose. Therefore, since cannabis has 
shown to be an effective analgesic and has not shown to be significantly associated with death 
due to overdose as opioids have, it is important to determine the public’s opinion regarding its 
use. This is because the usefulness of cannabis as an opioid substitute is limited if an 
overwhelming portion of the population does not believe it should be available for medicinal use. 
Public Opinion and Media 
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 According to a 2017 Pew Research Center survey of a nationally representative sample, 
roughly 6 out of every 10 Americans (61%) believe marijuana should be legalized (Hartig & 
Geiger, 2018). Not only was this percentage up 4% from the previous year, but it was also nearly 
double that from 2000, which was 31% (Hartig & Geiger, 2018). The survey also showed that 
almost all generations support the legalization of marijuana, with the Silent Generation (people 
born between 1928-1945) being the only one opposed (Hartig & Geiger, 2018). Based off this 
data, it appears the majority of Americans support the legalization of cannabis, not only for 
medicinal purposes, but for recreational use as well; however, future surveys should make the 
distinction of whether the participants believe it should be legalized for medical use, recreational 
use, both, or neither. Even so, based on this nationally representative survey, it appears the 
majority of Americans support the use of cannabis. It is then important to determine the 
relationship between certain variables that either influence or are influenced by public opinion on 
cannabis use.  
One such variable is media, which studies have shown is correlated to public opinion on a 
variety of issues. For example, Pearl, Puhl, and Brownell (2012) found that participants who 
viewed positive images of obese models had less of a negative attitude towards the models than 
those who viewed stigmatized images. In another study, Young, Norman, and Humphreys (2008) 
found that infectious diseases which received more media coverage were perceived as being 
more severe than diseases with similar objective severity but had received fewer media coverage. 
Based on these studies, media and public opinion have shown to be correlated to one another. 
Therefore, the purpose of this study is to determine the relationship between media and public 
opinion regarding cannabis as an opioid substitute. Specifically, this study will determine the 
relationship between the primary media source individuals between the ages of 18 and 30 use 
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and what their opinions are towards the use of cannabis as an opioid substitute. Since this is such 
a controversial and pressing issue in society, politics, and the field of medicine and 
rehabilitation, research into the opinions of young individuals—the voters of tomorrow—is 
imperative and could foreshadow future changes to laws and procedures involving the 
prescription rate of both cannabis and opioids. 
Our hypotheses are as follows: (1) The majority of participants will believe opioids are 
more addictive and more harmful to one’s health than cannabis; (2) The primary media source 
someone uses will be significantly correlated to their opinion on the use of cannabis as an opioid 
substitute. 
Rationale for Current Study 
 Determining the relationship between media and public opinion regarding cannabis and 
opioids is important because it could suggest certain media sources provide biased information 
about this topic. While there has been research into public opinion about opioids and cannabis, 
the literature around the relationship between the primary media source someone uses and their 
opinion concerning the use of cannabis as an opioid substitute is lacking. Therefore, this study 
will examine public opinion regarding the use of cannabis as an alternative to opioids. However, 
it is important to note that this study cannot prove a causal or directional relationship because no 
variable will be manipulated by the researchers. As a result, this study’s main purpose is to 
discern if future research into this topic is warranted. 
Methods 
Study Design 
 An online survey was created and approved by the Institutional Review Board (IRB) 
before data collection began. Once approved, the survey was administered to participants 
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through Qualtrics. Participants accessed the survey using the link provided to them by various 
faculty members. After the participants completed the survey, their responses were recorded and 
stored by Qualtrics. 
Participants 
Participants (n=134) consisted of college students from who were between 18 and 30 
years old. All participants were recruited via emails from faculty. The demographic breakdown 
of the participants is reported in Table 1. 
Table 1. Participant demographic information. 
Gender Age Race Religion Political Party 
Male 18 Years Old White Christianity Democrat 
24 23 80 102 38 
     
Female 19 Years Old 
Black / African 
American 
Hinduism Republican 
110 23 25 7 52 
     




 35 21 2 13 
     
 21 Years Old Hispanic Islam None 
 24 6 5 28 
     
 22 Years Old Mixed Other Other 
 11 3 18 3 
     
 23-29 Years Old    
 18    
 
Survey 
An online survey was created using the service Qualtrics. The first section of the survey 
included demographical questions about age, gender, race/ethnicity, current academic class 
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standing, religion, the region of the United States in which the participant was raised, and 
political party affiliation. 
The next section included questions about media consumption. The participants were 
asked what they use as their primary media source (e.g., CNN, Fox News, Social Media, etc.); 
how much time they spend per day on their primary media source; and what their closest family 
member(s) use(s) as their primary media source. This section also included questions that asked 
participants to rank their level of support on a 5-point Likert scale—1 being strongly disagree 
and 5 being strongly agree. The questions included whether the participants believe their primary 
media source has the potential of providing biased information; if their primary media source can 
influence their opinion on cannabis and/or opioids (asked as two separate questions); and if the 
primary media source their closest family member(s) use(s) can influence their opinion on the 
use of cannabis and/or opioids (again, asked as two separate questions). However, they were not 
asked these last two questions about their family members if they answered “Unsure” for the 
question regarding which primary media source their closest family member(s) use(s). This was 
done to avoid any guessing done by the participants, which could have potentially skewed the 
results. 
Furthermore, the participants were asked about their opinion regarding cannabis and 
opioids. They were asked if they have ever taken a prescription opioid before; if they believe 
there is an issue with the prescription rate of opioids in the United States; which one they believe 
is more addictive; which one they believe is more harmful to one’s health; if one, both or neither 
should be available to patients through prescription; and if one, both, or neither should be 
available over-the-counter. Lastly, the participants were asked to rank their level of support for 
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the use of cannabis as an opioid substitute on a 5-point scale from “strongly do not support” to 
“strongly do support”. 
Statistical Analysis 
The data was analyzed in Excel using Chi-square and Pearson correlation tests to 
determine the relationship between media and public opinion regarding cannabis as an opioid 
substitute, as well as the participants’ overall opinion regarding opioids and cannabis. Chi-square 
testing was used because it is the commonly accepted form of analysis for comparing categorical 
data to determine how well the observed data aligns with the expected data that would be seen if 
the categorical variables are independent of one another (Statistics Solutions, n.d.). Additionally, 
Pearson correlation testing was used to test if there was a linear relationship between any of the 
variables. 
Results 
Opinion on Cannabis and Opioids 
 As shown in Table 2, the majority of participants responded with opioids when asked 
which analgesic drug they believe is more addictive and harmful to one’s health. 
Table 2. Participant responses when asked if they believe opioids or cannabis is more addictive 
and more harmful to one's health. 
More Harmful More Addictive 
Opioids Opioids 
114 (85%) 103 (77%) 
Cannabis  Cannabis  
8 (6%) 6 (4%) 
Unsure Unsure 
12 (9%) 25 (19%) 
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Binomial distribution was used to test the probability of seeing a sample such as this one. 
If the “unsure” responses are excluded, the probability of having 114 out of 122 individuals 
respond saying they believe opioids are more harmful than cannabis is 1.81 x 10-25. Furthermore, 
the probability of having 103 out of 109 individuals respond saying they believe opioids are 
more addictive than cannabis is 3.12 x 10-24. Given such low probabilities, it is nearly impossible 
that this data is of random chance. Therefore, we conclude that the number of participants who 
answered opioids for the previously mentioned questions is not only significant but also a 
substantial majority of the responses. 
Participants were also asked to rank their support for the use of cannabis as an opioid 
substitute. Their responses are reported in the following table: 
Table 3. Participants' responses when asked to rank their level of support for the use of cannabis 
as an opioid substitute. 
Strongly Do Not 
Support 
Do Not Support Neutral Support 
Strongly Do 
Support 
5 (4%) 16 (12%) 37 (27%) 47 (35%) 29 (22%) 
 
As reported in Table 3, the majority (57%) of participants supported or strongly supported the 
use of cannabis as an opioid substitute, while only 16% were against it. 
Media vs Opinion on Cannabis as an Opioid Substitute 
Chi-square testing and bivariate analysis were both used to test if there is a significant 
relationship between the primary media source someone uses and their opinion on the use of 
cannabis as an alternative to opioids as an analgesic medication. For both forms of analysis, 
media was divided into two separate categories, traditional media and social media. Traditional 
media consisted of Fox News, CNN, NBC, MSNBC, ABC, NPR, radio stations, national 
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newspapers, and local newspapers; while social media consisted of Facebook, Twitter, 
Instagram, and YouTube. 
Table 4. The primary media sources the participants use, as well as their opinions on the use of 













Traditional Media 2 7 16 15 10 50 
Social Media 3 9 21 32 19 84 
Total 5 16 37 47 29 134 
 
Neither chi-square (χ2 = 1.540, df = 4, p = 0.82) nor Pearson correlation (r = 0.079) tests 
showed any significant relationship between media and opinion on cannabis as an opioid 
substitute. Therefore, we conclude that there is not a significant relationship between the media 
source an individual uses and his/her opinion on the use of cannabis as a substitute for opioids as 
an analgesic medication. 
Conclusion 
The primary intent of this study was to determine if the primary media source an 
individual uses affects his or her opinion on the use of cannabis as an opioid substitute. After 
conducting chi-square and Pearson correlation tests to analyze 134 survey responses, we found 
that the primary media source participants used was not significantly correlated to their opinion 
regarding the use of cannabis as an opioid substitute. However, we did find that the majority of 
participants believed opioids are more harmful and more addictive than cannabis. Furthermore, 
we also found that the majority (57%) of respondents do support the use of cannabis as an opioid 
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substitute. Therefore, we conclude that there is evidence to suggest (1) media and public opinion 
on the use of cannabis as an opioid substitute are not significantly correlated to one another; (2) a 
majority of the population believes cannabis should be available as an alternative to opioids for 
pain relief; and (3) a significant majority of the population believes opioids are more addictive 
and more harmful than cannabis. 
Discussion 
Based on our results, we concluded that a majority (57%) of the population support the 
availability of cannabis as an opioid substitute for analgesic purposes. This is in agreement with 
other studies that also tested the public’s opinion on cannabis and opioids. For example, the 
previously cited 2017 Pew Research Center survey found that roughly 6 out of every 10 
Americans (61%) believe marijuana should be legalized (Hartig & Geiger, 2018). Since our 
results are similar, it helps further validate the theory that a growing majority of Americans are 
in support of cannabis use for pain relief. 
We also concluded that the media source an individual uses is not significantly correlated 
to their opinion regarding the use of cannabis as an alternative to opioids due to the fact that 
almost all respondents shared roughly the same opinion on the dangers of opioid use. While it 
was not the focus of our research, we also determined if gender, political party affiliation, age, or 
religion are significantly related to opinion on cannabis as an opioid substitute. After conducting 
chi-square and Pearson correlation tests, we found no significant relationship between any of the 
aforementioned variables and opinion on cannabis as an alternative to opioids. 
Additionally, for our analysis, we broke media into two separate categories; traditional 
media (e.g., Fox News, ABC, etc.) and social media (e.g., Facebook, Twitter, etc.). One possible 
alteration to our research that should be conducted in the future would be to use each individual 
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media source instead of grouping them into broad categories. Our rationale for grouping media 
sources into categories in this study was due to the small number of responses. Since the vast 
majority of participants chose social media as their primary media source (84 of 134 responses), 
none of the individual traditional media sources had a significant number of selections—Fox 
News had the most with 15. Consequently, they were grouped into one category so that we could 
conduct a reliable analysis. 
 Furthermore, one area of concern is that, while not every participant chose social media 
as their primary source of information, it is unlikely that they do not use it at all. Therefore, 
social media might still influence their opinion on cannabis as an opioid substitute even though 
they use another media source more often. Thus, our findings might have been affected, but 
unfortunately, there is no way of knowing given the questions asked in our survey. 
 Lastly, there is ample opportunity to expand upon our research. Future studies should test 
if our findings are similar to those seen in other populations besides college students between the 
ages of 18 and 30. For example, even though college students may be the voters of tomorrow, the 
Silent/Greatest generation (people born before 1945) and Baby Boomer generation (1946-1964) 
had the highest voter turnout for the 2016 election, while the Millennial (1981-1996) and Post-
Millennial (after 1997) generations had the smallest voter turnout (Fry, 2018). Therefore, it is 
important to know if our findings hold true for those generations. Since older individuals may 
use different media sources and have varying opinions than college students, it is reasonable to 
suspect that our findings may have been different if we researched an older population. Likewise, 
the same issue arises with a younger population. 
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